Literature DB >> 33801923

Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology.

Gennady Sukhikh1,2, Ulyana Petrova1, Andrey Prikhodko1, Natalia Starodubtseva1,3, Konstantin Chingin4, Huanwen Chen4, Anna Bugrova1,5, Alexey Kononikhin1,6, Olga Bourmenskaya1, Alexander Brzhozovskiy1,6, Evgeniya Polushkina1, Galina Kulikova1, Alexander Shchegolev1, Dmitry Trofimov1, Vladimir Frankevich1, Evgeny Nikolaev6, Roman G Shmakov1.   

Abstract

The effects of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in women on the gestation course and the health of the fetus, particularly in the first and second trimesters, remain very poorly explored. This report describes a case in which the normal development of pregnancy was complicated immediately after the patient had experienced Coronavirus disease 2019 (COVID-19) at the 21st week of gestation. Specific conditions included critical blood flow in the fetal umbilical artery, fetal growth restriction (1st percentile), right ventricular hypertrophy, hydropericardium, echo-characteristics of hypoxic-ischemic brain injury (leukomalacia in periventricular area) and intraventricular hemorrhage at the 25th week of gestation. Premature male neonate delivered at the 26th week of gestation died after 1 day 18 h due to asystole. The results of independent polymerase chain reaction (PCR), mass spectrometry and immunohistochemistry analyses of placenta tissue, umbilical cord blood and child blood jointly indicated vertical transmission of SARS-CoV-2 from mother to the fetus, which we conclude to be the major cause for the development of maternal vascular malperfusion in the studied case.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; fetal growth restriction; pregnancy; vertical transmission

Mesh:

Year:  2021        PMID: 33801923      PMCID: PMC7999228          DOI: 10.3390/v13030447

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  33 in total

1.  Antibodies in Infants Born to Mothers With COVID-19 Pneumonia.

Authors:  Hui Zeng; Chen Xu; Junli Fan; Yueting Tang; Qiaoling Deng; Wei Zhang; Xinghua Long
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  The association of maternal floor infarction of the placenta with adverse perinatal outcome.

Authors:  R L Andres; W Kuyper; R Resnik; K M Piacquadio; K Benirschke
Journal:  Am J Obstet Gynecol       Date:  1990-09       Impact factor: 8.661

3.  Second-Trimester Miscarriage in a Pregnant Woman With SARS-CoV-2 Infection.

Authors:  David Baud; Gilbert Greub; Guillaume Favre; Carole Gengler; Katia Jaton; Estelle Dubruc; Léo Pomar
Journal:  JAMA       Date:  2020-06-02       Impact factor: 56.272

4.  Clinicopathological characteristics of miscarriages featuring placental massive perivillous fibrin deposition.

Authors:  Eun Na Kim; Joong Yeup Lee; Jae-Yoon Shim; Doyeong Hwang; Ki Chul Kim; So Ra Kim; Chong Jai Kim
Journal:  Placenta       Date:  2019-07-12       Impact factor: 3.481

5.  SARS-CoV-2 infection of the placenta.

Authors:  Hillary Hosier; Shelli F Farhadian; Raffaella A Morotti; Uma Deshmukh; Alice Lu-Culligan; Katherine H Campbell; Yuki Yasumoto; Chantal Bf Vogels; Arnau Casanovas-Massana; Pavithra Vijayakumar; Bertie Geng; Camila D Odio; John Fournier; Anderson F Brito; Joseph R Fauver; Feimei Liu; Tara Alpert; Reshef Tal; Klara Szigeti-Buck; Sudhir Perincheri; Christopher Larsen; Aileen M Gariepy; Gabriela Aguilar; Kristen L Fardelmann; Malini Harigopal; Hugh S Taylor; Christian M Pettker; Anne L Wyllie; Charles Dela Cruz; Aaron M Ring; Nathan D Grubaugh; Albert I Ko; Tamas L Horvath; Akiko Iwasaki; Uma M Reddy; Heather S Lipkind
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

6.  A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery.

Authors:  Xiaotong Wang; Zhiqiang Zhou; Jianping Zhang; Fengfeng Zhu; Yongyan Tang; Xinghua Shen
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

7.  Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review.

Authors:  Ziyi Yang; Min Wang; Ziyu Zhu; Yi Liu
Journal:  J Matern Fetal Neonatal Med       Date:  2020-04-30

8.  The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study.

Authors:  Mengmeng Li; Liang Chen; Jingxiao Zhang; Chenglong Xiong; Xiangjie Li
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

9.  Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review.

Authors:  J Juan; M M Gil; Z Rong; Y Zhang; H Yang; L C Poon
Journal:  Ultrasound Obstet Gynecol       Date:  2020-07       Impact factor: 8.678

10.  Clinical course of novel COVID-19 infection in pregnant women.

Authors:  Roman G Shmakov; Andrey Prikhodko; Evgeniya Polushkina; Elena Shmakova; Aleksey Pyregov; Vladimir Bychenko; Tatyana V Priputnevich; Grigory O Dolgushin; Ekaterina Yarotskaya; Oleg Pekarev; Nikolai Bolibok; Dmitriy Degtyarev; Gennady T Sukhikh
Journal:  J Matern Fetal Neonatal Med       Date:  2020-11-29
View more
  7 in total

Review 1.  Validity of Apgar Score as an Indicator of Neonatal SARS-CoV-2 Infection: A Scoping Review.

Authors:  Melissa Chao; Carlo Menon; Mohamed Elgendi
Journal:  Front Med (Lausanne)       Date:  2022-01-11

2.  Integrated Analysis Reveals the Characteristics and Effects of SARS-CoV-2 Maternal-Fetal Transmission.

Authors:  Ziliang Huang; Shuting Xia; Shiqiang Mei; Yanzi Wen; Jialiu Liu; Chengzhi Dong; Wenxin Chen; Peijie Yu; Lianghu Qu; Yanmin Luo; Lingling Zheng
Journal:  Front Microbiol       Date:  2022-01-27       Impact factor: 5.640

Review 3.  SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants.

Authors:  Claudia P Figueiredo; Fabrícia L Fontes-Dantas; Andrea T da Poian; Julia R Clarke
Journal:  Neuropharmacology       Date:  2021-10-16       Impact factor: 5.250

4.  COVID-19 Infection in Pregnancy: Obstetrical Risk Factors and Neonatal Outcomes-A Monocentric, Single-Cohort Study.

Authors:  Antonella Vimercati; Rosalba De Nola; Paolo Trerotoli; Maria Elvira Metta; Gerardo Cazzato; Leonardo Resta; Antonio Malvasi; Archiropita Lepera; Ilaria Ricci; Manuela Capozza; Nicola Laforgia; Ettore Cicinelli
Journal:  Vaccines (Basel)       Date:  2022-01-21

5.  Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health.

Authors:  Jingsi Chen; Lili Du; Feiyang Wang; Xuan Shao; Xiaoyi Wang; Wenzhe Yu; Shilei Bi; Dexiong Chen; Xingfei Pan; Shanshan Zeng; Lijun Huang; Yingyu Liang; Yulian Li; Rufang Chen; Fengwu Xue; Xiuying Li; Shouping Wang; Manli Zhuang; Mingxing Liu; Lin Lin; Hao Yan; Fang He; Lin Yu; Qingping Jiang; Zhongtang Xiong; Lizi Zhang; Bin Cao; Yan-Ling Wang; Dunjin Chen
Journal:  Cell Prolif       Date:  2022-02-09       Impact factor: 8.755

6.  Seroprevalence of antibodies against to SARS-CoV 2 in umbilical cord blood in two hospital centers in Córdoba and Sucre, Colombia.

Authors:  José Berrocal; Vaneza Tique-Salleg; Jorge Miranda; German Arrieta; Daniel Echeverri; Gloria Peñate; Doris Spath; Ameth Salim Mattar; Salim Mattar
Journal:  J Infect Public Health       Date:  2022-09-01       Impact factor: 7.537

Review 7.  The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity.

Authors:  Iwona Bukowska-Ośko; Marta Popiel; Paweł Kowalczyk
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.